| Identification |
| Name: | Butanoic acid,2,3-dihydroxy-2-(1-methylethyl)-,[(1R,7aR)-2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl]methyl ester,(2S,3S)- |
| Synonyms: | Butanoicacid, 2,3-dihydroxy-2-(1-methylethyl)-,(2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl ester, [1R-[1a,7(2S*,3S*),7ab]]-; Lycopsamine (7CI,8CI);(+)-Lycopsamine; Retronecine 9-((-)-viridiflorate) |
| CAS: | 10285-07-1 |
| Molecular Formula: | C15H25 N O5 |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C15H25NO5/c1-9(2)15(20,10(3)17)14(19)21-8-11-4-6-16-7-5-12(18)13(11)16/h4,9-10,12-13,17-18,20H,5-8H2,1-3H3/t10-,12+,13+,15-/m0/s1 |
| Molecular Structure: |
 |
| Properties |
| Transport: | 1544 |
| Flash Point: | 234°C |
| Boiling Point: | 463.3°Cat760mmHg |
| Density: | 1.26g/cm3 |
| Refractive index: | 1.567 |
| Packinggroup: | III |
| Flash Point: | 234°C |
| Safety Data |
| |
 |
